Thiotepa-based Conditioning Pre-Allo SCT
Phase 1 Trial of Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies
More Information
- Trial Status
- Not yet accepting
- Trial Phase
- Phase 1
- Enrollment
- 48 patients (estimated)
- Tags
- Alkylating Agent, Allogeneic Stem Cell Transplant, Pre-Allogeneic Stem Cell Transplant
- Trial Type
- Treatment
- Last Update
- SparkCures ID
- 2252
- NCT Identifier
- NCT07565220
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.